e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Mechanisms of inflammatory reactions in asthma, COPD and models of allergic airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Establishment of an experimental BALB/c mouse model for studies on isocyanate asthma
L. Z. Sun, S. Elsayed, A. Irgens, N. P. Aardal, T. B. Aasen (Bergen, Norway)
Source:
Annual Congress 2005 - Mechanisms of inflammatory reactions in asthma, COPD and models of allergic airway disease
Session:
Mechanisms of inflammatory reactions in asthma, COPD and models of allergic airway disease
Session type:
Thematic Poster Session
Number:
3758
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Z. Sun, S. Elsayed, A. Irgens, N. P. Aardal, T. B. Aasen (Bergen, Norway). Establishment of an experimental BALB/c mouse model for studies on isocyanate asthma. Eur Respir J 2005; 26: Suppl. 49, 3758
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Murine models of asthma
Source: Eur Respir J 2003; 22: 374-382
Year: 2003
Single versus multiple challenge in a mouse model of chemical-induced asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 587s
Year: 2005
Murine models of asthma
Source: Guideline 2003
Year: 2003
Allergen-induced inflammation and airway responsiveness in a mouse model of asthma: comparison between C57BL/6 and Th2-prone BALB/c mice
Source: Eur Respir J 2003; 22: Suppl. 45, 484s
Year: 2003
Value of genetically modified mice as models of asthma and allergy
Source: Annual Congress 2007 - PG11 - Translation of animal models to human airway disease
Year: 2007
Genetic analysis of antigen-induced airway manifestations of asthma using recombinant congenic mouse strains
Source: Eur Respir J 2003; 22: Suppl. 45, 484s
Year: 2003
Establishment of a murine asthma exacerbation model by combining OVA exposure with either RSV or influenza infection
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Development of papain-induced asthma-COPD overlap mice model
Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Year: 2019
Experimental asthma does not impact chemical lung carcinogenesis in mice
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Effects of treatment with angiotensin-(1-7) on antigen sensitization of murine experimental model of asthma
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
Development of a mouse model of airway inflammation and remodeling in experimental asthma
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
Stability of reference genes in five C57/Bl6 models of lung inflammation
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
The effect of anti-IL-33 antibody and soluble ST2 in a murine model of allergic asthma
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
Environmental tobacco smoke (ETS) in allergic asthma: A parallel exposure study in human subjects and sensitized allergic Balb/c mice
Source: Annual Congress 2011 - Smoking-related disorders and smoking prevention
Year: 2011
A murine ovalbumin model exhibits molecular features of steroid insensitive human asthma
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Developing a chronic murine model that better reflects the clinical features of the human asthma
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Analysis of mucus production in mouse models of allergic asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
Murine asthma induction: adjuvant and adjuvant-free models produce comparable phenotypes
Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models
Year: 2008
Improving of experimental allergic asthma by decreased Th2 responses in OGR-1 knockout mice
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Clinical and experimental investigation of patients with allergic rhinitis and animal models
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept